Treatment Effects of Probiotic in Non Alcoholic Fatty Liver Disease
Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 217
This Paper With 13 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_ZUMS-25-109_003
تاریخ نمایه سازی: 11 اردیبهشت 1400
Abstract:
Background and Objective: In the modern era, nonalcoholic fatty liver disease (NAFLD) is a huge burden on the shoulders of health systems around the world. On the other hand, lack of a specific and effective therapeutic approach has persuaded scientists to look for new treatments, among which probiotics have recently raised interest. The aim of this study was to investigate the effect of probiotics in non alcoholic fatty liver disease treatment.
Materials and Methods: In this randomized clinical trial, ۹۰ patient were enrelled with NAFLD and divided into two groups: ۴۵ patients in the diet and exercise group, and ۴۵ patients received ۵۰۰ mg/d Familacat capsules in addition to diet and exercise. Then the serum level changes of FBS, Triglycerides, Cholestrol, AST and ALT as well as weight and blood pressure were compared between the groups.
Results: In the FamiLact group, BMI, FBS, cholesterol, LDL, AST and ALT had improved significantly. In the control group, the only insignificantly changed variable was serum LDL. Comparison of the groups showed a significantly better improvement in the FamiLact group in terms of cholesterol and LDL changes. However in the control group, changes in blood pressure and HDL levels were significantly better.
Conclusion: FamiLact is a safe and effective probiotic in improving blood sugar, BMI and lipid profile values (except for HDL) in patients with NAFLD.
Key words: Probiotic, FamiLact, NAFLD
Keywords:
Authors
مریم جامه شورانی
Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran
عفت رفیعی
Dept.of Internal Medicine, Vliasr Hospital, Zanjan University of Medical Sciences, Zanjan, Iran
حسن نیشابوری
Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran
کوروش کمالی
Metabolic Diseases Research Center, Zanjan University of Medical Sciences, Zanjan, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :